Conference Details

2009 Best Practices in Primary Care
11/20/2009 - 11/21/2009

Donald E. Stephens Convention Center
5555 N. River Road
Rosemont , IL 60018
Phone: 847-692-2220

Who Should Attend

All primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.

Agenda

 
11/20/2009
6:30 am - 7:30 am Registration and Complimentary Continental Breakfast
7:30 am - 12:10 pm Morning Sessions
12:10 pm - 12:55 pm Complimentary Lunch
12:55 pm - 4:05 pm Afternoon Sessions

11/21/2009

6:30 am - 7:30 am Registration and Complimentary Continental Breakfast
7:30 am - 12:40 pm Morning Sessions
12:40 pm - 1:25 pm Complimentary Lunch
1:25 pm - 4:20 pm Afternoon Sessions

Venue Information

Meeting Room: Rooms 21-23, 32-34 (Level 2)

Parking: Parking is available in the Rosemont Public Parking Garage (located behind Embassy Suites) for $13 daily. Guests of the Hyatt Regency O'Hare can self park for $25 daily, or valet park for $28 daily.

Hotel Accommodations:
Hyatt Regency O'Hare
9300 Bryn Mawr Avenue
Rosemont, IL 60018
847-696-1234

With so many things to do and see, you might consider bringing your family and turning this conference trip into a vacation at the Hyatt Regency O'Hare. Please call 847-696-1234 and mention that you are with the Primary Care Education conference. Be sure to call no later than November 5, 2009, to guarantee your room rate of $129.00 for single/double occupancy per night. Rooms are limited!

Accreditation

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

AAPA
AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 13.25 hours of Category 1 credit for completing this program.

AANP
This program has been approved for 13.25 contact hours of continuing education (which includes 5.38 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0911381. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Topics

 
 PAD
 Prevent the Event: Early Detection and Management of the PAD Patient

Overview
PAD is frequently unrecognized and many patients at risk are currently not identified and treated. Current estimates are that 8-12 million Americans have PAD, with the highest incidence among those over 70 years of age, regardless of health status, and people over 50 years of age with diabetes mellitus. This lecture will overview the tremendous risk associated with PAD, discuss the major risk factors for developing PAD, and highlight the role of primary care in detecting and diagnosing the condition through increased use of ABI screening. Current therapies will be discussed including symptom improvement and prevention of future CV events with an emphasis on patient compliance issues.

Objectives
Identify the risk factors for those patients most at risk for PAD and therefore should be screened utilizing ABI

Name the 2 goals of management of PAD

Faculty
Kelly Anne Spratt, DO, FACC
Clinical Assistant Professor of Medicine
Cardiovascular Risk Intervention Program
University of Pennsylvania School of Medicine
Philadelphia, PA

Lawrence E. Mieczkowski, MD
Clinical Associate Professor of Medicine
Wright State University School of Medicine
Dayton, OH

 Insomnia
 Managing Insomnia in Primary Care: Understanding Current and Developing Pharmacological and Nonpharmacological Therapies

Overview
Insomnia, defined as complaints of disturbed sleep in the presence of adequate opportunity and circumstance for sleep, is the most common adult sleep pathology. Besides cognition, other pathologic processes have been deleteriously associated with insomnia, including cardiovascular morbidity and glycemic control. The latest evidence about sleep pathology will be presented, including spectral analysis that indicates sleep patterns, including slow wave sleep, are important, rather than just total sleep time. Nonpharmacologic approaches, as well as current and developing pharmacotherapies used to address these sleep pathologies will be described.

Objectives
Identify the underlying causes and comorbid conditions of insomnia for increased confidence in treatment

Assess the current and developing nonpharmacologic and pharmacologic approaches to the management of primary and co- morbid insomnia

Faculty
David Neubauer, MD
Assistant Professor, Department of Psychiatry,
Johns Hopkins University School of Medicine
Medical Director, Psychiatry Mobile Treatment Services,
Johns Hopkins Bayview Medical Center
Associate Director, Johns Hopkins Sleep Disorders Center

Paul P. Doghramji, MD, FAAFP
Family Physician
Collegeville Family Practice
Medical Director of Health Services, Ursinus College
Collegeville, PA

 Dyslipidemia
 Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions

Overview
This presentation will address early and aggressive LDL-C management and the clinical challenges of goal attainment. Clinicians will be provided with pathways and knowledge to help them improve their patient outcomes by goal attainment of the healthy lipid profile. Discussion will be applicable to clinicians' practice including lifestyle changes of diet and exercise, along with pharmacologic treatment options available for lipid management in order to give the appropriate tools to get patients to their true LDL goals.

Objectives
Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies

Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals

Faculty
Jerome D. Cohen, MD, FACP, FACC, FAHA
Professor of Internal Medicine
Saint Louis University School of Medicine
St. Louis, MO

James A. Underberg, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine
NYU Medical School
New York, NY

 Smoking Cessation
 Do Ask, Do Tell: Successful Smoking Interventions

Overview
Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking.

Objectives
Screen all patients for smoking status and design individualized cessation interventions for patients who smoke

Commit to active follow-up with patients along the smoking cessation path

Faculty
Thomas C. Bent, MD
Medical Director and Chief Operating Officer
Laguna Beach Community Clinic
Laguna Beach, CA
Associate Clinical Professor
Department of Family Medicine
University of California, Irvine
Irvine, CA


 Rhinitis
 Diagnostic Work-up and Management of Histamine-induced Disorders: Allergic Rhinitis and Chronic Urticaria

Overview
Allergic rhinitis and chronic idiopathic urticaria, chronic histamine-induced conditions, negatively and significantly impact patient health and quality of life. However, current treatment options are only modestly successful, and obstacles remain to improving outcomes. Diagnostic Work-up and Management of Histamine-induced Disorders: Allergic Rhinitis and Chronic Urticaria will provide primary care clinicians with practical, evidence-based solutions for managing the challenges of these conditions, with an emphasis on finding effective treatments, managing side effects, and ensuring patient compliance.

Objectives
Identify strategies to overcome barriers for adequate control of allergic rhinitis symptoms

Create treatment strategies to improve outcomes for patients with chronic idiopathic urticaria

Faculty
Mark L. Corbett, MD
Associate Clinical Professor
Division of Allergy/Immunology
University of Louisville School of Medicine
Louisville, KY

Michael S. Blaiss, MD
Clinical Professor of Pediatrics and Medicine
Division of Clinical Immunology and Allergy
University of Tennessee Health Science Center
Memphis, TN

 Migraine
 Diagnosis and Effective Treatment of Migraine to Limit Allodynia and Progression to Chronic Headache

Overview
This educational activity will describe and reinforce tools that enable clinicians to efficiently recognize and diagnose migraine that may have been previously undiagnosed and untreated, or who may have lapsed from treatment, and to communicate realistic treatment goals to reach the goal of improved patient outcomes.

Objectives
Identify the symptoms and patterns of headache for accurate assessment of migraine, including associated risks for progression to chronic migraine, and utilize simple screening tools to overcome diagnostic challenges

Create a migraine management strategy tailored to individual patient needs that incorporates a stratified approach to pharmacological and nonpharmacological therapies and communication of realistic treatment goals to help improve patient outcomes

Faculty
Frederick R. Taylor, MD, FAHS
Adjunct Professor of Neurology
University of Minnesota School of Medicine
Director, Park Nicollet Headache Clinic and Research Center
Minneapolis, MN

Susan Hutchinson, MD
Associate Clinical Professor
Department of Family Medicine
University of CA, Irvine Medical Center
Irvine, CA

 Gout
 Front-line Management of Gout: A Step-by-Step Guide to Best Practice

Overview
This program will address the key "must-know" points in gout management. The provision of case-based presentations will provide primary care clinicians with a clear step-by-step comprehension of how to manage gout and establish effective, supportive patient interaction to optimize life-long adherence to life-style and therapeutic regimens. There will be opportunities to interact with the faculty and obtain their expert opinions on clinical issues faced in managing patients with gout.

Objectives
Identify that the long-term goal of gout treatment is to reduce serum urate to <6.0 mg/dL and to define the key steps in selecting and individualizing urate lowering therapy according to the disease stage; together with recognizing the importance of monitoring serum urate levels

Educate patients that an important factor in successful management includes their long-term commitment to adherence with the recommended life-style and drug interventions

Faculty
D. Wayne Bell, MD
Family Practitioner
Bowling Green Family Care Center
Medical Director, Diabetes Day Care Center
Wood County Hospital
Bowling Green, OH

Robert A. Terkeltaub, MD
Chief of Rheumatology
Veterans Administration Medical Center
Professor of Medicine and Associate Division Director
University of California, San Diego
San Diego, CA


 Adult Vaccines
 Adult Immunizations: Overcoming Obstacles in Primary Care

Overview
Despite the great advances in medical care represented by adult immunization, the challenges continue to be numerous and varied. This activity will explore the barriers, clarify the "myths," and provide the most updated information on adult vaccines to increase immunization rates.

Objectives
Identify the Advisory Committee on Immunization Practices (ACIP) recommended adult vaccines and the recommended immunization schedules for each ACIP recommended adult vaccine

Increase knowledge and confidence regarding safety, risks, benefits, and side effects of adult immunizations and create a strategy to increase patient immunization rates, including the use of a health maintenance form or other tool for immunization review

Faculty
Gary A. Richwald, MD, MPH
Communicable Disease Specialist
Clinical Virologist
Los Angeles, CA


 Sleep Apnea
 Obstructive Sleep Apnea: A Practitioner-Driven Educational Initiative

Overview
The National Heart Lung Blood Institute (NHLBI) reports that there are 12 million Americans with obstructive sleep apnea (OSA). Despite the prevalence of this common condition, studies show that 80 -90% of people with OSA remain undiagnosed. Patients who suffer silently with undiagnosed OSA face significant quality of life and associated health issues. Identifying patients with OSA can be a challenge in the busy office setting, and requires the clinician to maintain a high level of suspicion based on sometimes subtle patient complaints, physical exam findings, and OSA risk factors. Once diagnosed and treatment is initiated, successful management is the cornerstone to better patient outcomes. As the first medical contact for most patients with OSA primary care clinicians are crucial for both recognition and management of patients with OSA. This educational activity will provide both the science and the skills that can make significant improvements in the lives of patients with OSA.

Objectives
Recognize the signs and symptoms of OSA and utilize simple assessment questions to identify the possibility of OSA

Identify strategies to assess and monitor patient adherence to treatment for OSA

Faculty
David Neubauer, MD
Assistant Professor, Department of Psychiatry,
Johns Hopkins University School of Medicine
Medical Director, Psychiatry Mobile Treatment Services,
Johns Hopkins Bayview Medical Center
Associate Director, Johns Hopkins Sleep Disorders Center

Paul P. Doghramji, MD, FAAFP
Family Physician
Collegeville Family Practice
Medical Director of Health Services, Ursinus College
Collegeville, PA

 Opioid Therapy
 Opioid Therapy for Patients with Pain: Strategies for Risk Assessment and Management

Overview
Opioids provide effective pain management for acute and cancer pain and are useful in treating patients with chronic non-cancer pain who have not responded to other pain management therapies. Because of potential opioid abuse, patients and physicians may be reluctant to initiate opioid therapy for pain relief. This program will examine clinical strategies and recently published guidelines to balance effective opioid therapy against the risk of opioid misuse, abuse, and diversion.

Objectives
Implement clinical strategies designed to provide safe and effective use of opioid therapy while addressing the issues of opioid abuse, misuse, and diversion

Utilize recommendations from the American Pain Society/American Academy of Pain Medicine's Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain in clinical practice

Faculty
Paul J. Christo, MD, MBA
Assistant Professor
Director, Multidisciplinary Pain Fellowship Program
Department of Anesthesiology and Critical Care Medicine
Division of Pain Medicine
The Johns Hopkins University of School of Medicine
Baltimore, MD